trending Market Intelligence /marketintelligence/en/news-insights/trending/m2px5jb6wwzezgqs3aaujq2 content esgSubNav
In This List

PTC Therapeutics prices public offering

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


PTC Therapeutics prices public offering

PTC Therapeutics Inc. priced its previously announced public offering of 4 million shares at $27.04 per share.

Credit Suisse and Citigroup are acting as lead book-running managers for the offering, which is expected to close by April 3.

RBC Capital Markets is acting as a book-running manager.

The South Plainfield, N.J.-based biotechnology company has granted the underwriters a 30-day option to acquire an additional 600,000 shares.